register

News & Trends - MedTech & Diagnostics

Cutting-edge lab to break barriers in breast cancer detection: A new era of screening unveiled

Health Industry Hub | May 17, 2023 |

MedTech & Diagnostics News: Australia’s BCAL Diagnostics has unveiled its cutting-edge development and clinical service laboratory in Sydney. This momentous occasion marks a significant milestone for BCAL as it forges ahead in its mission to revolutionise breast cancer screening.

The company’s non-invasive blood screening technology, boasting an impressive 91% sensitivity and 80% specificity, is set to complement existing breast cancer screening methods, including mammography. BCAL aims to develop a comprehensive monitoring and screening test suitable for women of all ages and backgrounds, regardless of their location.

Equipped with the latest Liquid Chromatography Mass Spectrometry (LCMS) platforms, the newly established laboratory will serve as a hub for advancing BCAL’s ground-breaking clinical research findings. It will also play a pivotal role in collaborating with Precion, BCAL Diagnostics’ US commercialisation partner, to establish and validate workflows, test protocols, and algorithms for the innovative BCAL blood screening tool. Additionally, the laboratory will facilitate ongoing and planned clinical validation studies.

The completion of these studies and the subsequent accreditations will enable BCAL’s blood screening tool to be made available to medical professionals and patients as an in-house developed test. Under this system, patient samples will be collected and forwarded to BCAL’s laboratory where they will undergo testing to identify the proprietary BCAL lipid signature expressed by breast cancer cells.

“The opening of our soon-to-be fully commercial and accredited laboratory brings us one step closer to accomplishing this goal,” declared Jayne Shaw, Executive Chair of BCAL Diagnostics.

“Not only will this laboratory serve as a catalyst for our current and future test developments, but it will also provide market access opportunities for other companies seeking entry into the Australian market.”

BCAL will present a poster entitled Lipodomic Signature from Plasma to Detect Localised Breast Cancer at the highly anticipated 2023 ASCO Annual Meeting in June.

With the opening of its state-of-the-art laboratory, BCAL Diagnostics’ blood screening technology inches closer to transforming the landscape of breast cancer screening and diagnosis.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Government commissions review as 70% of private hospitals face financial crisis

Government commissions review as 70% of private hospitals face financial crisis

Health Industry Hub | June 14, 2024 |

MedTech & Diagnostics News: Despite playing a crucial role in providing acute care and surgical services, a staggering 70% of […]

More


News & Trends - Pharmaceuticals

Pharmacy Guild echoes ACCC red flags over Chemist Warehouse-Sigma deal

Pharmacy Guild echoes ACCC red flags over Chemist Warehouse-Sigma deal

Health Industry Hub | June 14, 2024 |

Pharma News: The Pharmacy Guild of Australia has echoed the significant concerns of the Australian Competition and Consumer Commission (ACCC) […]

More


News & Trends - MedTech & Diagnostics

Competition watchdog raises concerns over cancer care provider's expansion plans

Competition watchdog raises concerns over cancer care provider’s expansion plans

Health Industry Hub | June 14, 2024 |

MedTech & Diagnostics News: A leading provider of cancer care services in Australia, faces scrutiny from the Australian Competition and […]

More


News & Trends - Biotechnology

Aussie biotech secures first local CAR T patent

Aussie biotech secures first local CAR T patent

Health Industry Hub | June 13, 2024 |

Biotech News: A Melbourne-based biotechnology company which specialises in developing immune cell therapies for cancer treatment, has been granted its […]

More


This content is copyright protected. Please subscribe to gain access.